Taipei Exchange - Delayed Quote TWD

Dr. Wu Skincare Co., Ltd. (6523.TWO)

141.00
+2.00
+(1.44%)
At close: May 16 at 1:14:11 PM GMT+8
Loading Chart for 6523.TWO
  • Previous Close 139.00
  • Open 139.00
  • Bid 140.00 x --
  • Ask 140.50 x --
  • Day's Range 139.00 - 142.00
  • 52 Week Range 127.50 - 193.00
  • Volume 50,467
  • Avg. Volume 78,642
  • Market Cap (intraday) 6.352B
  • Beta (5Y Monthly) 0.12
  • PE Ratio (TTM) 13.61
  • EPS (TTM) 10.36
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield 11.00 (8.00%)
  • Ex-Dividend Date Mar 27, 2025
  • 1y Target Est --

Dr. Wu Skincare Co., Ltd. engages in the research, development, production, wholesale, and retail of cosmetics and skincare products in Taiwan and internationally. The company offers collagen peptide powders, cleansers, masks, toners, serums, hydrating lotions/creams/gels, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care. The company was incorporated in 2003 and is based in Taipei, Taiwan.

www.drwu.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6523.TWO

View More

Performance Overview: 6523.TWO

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6523.TWO
4.72%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.17%

1-Year Return

6523.TWO
18.66%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.53%

3-Year Return

6523.TWO
122.37%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
37.37%

5-Year Return

6523.TWO
273.71%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
101.98%

Compare To: 6523.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6523.TWO

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    6.35B

  • Enterprise Value

    5.41B

  • Trailing P/E

    13.60

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.14

  • Price/Book (mrq)

    4.18

  • Enterprise Value/Revenue

    4.36

  • Enterprise Value/EBITDA

    9.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    38.35%

  • Return on Assets (ttm)

    18.67%

  • Return on Equity (ttm)

    32.52%

  • Revenue (ttm)

    1.24B

  • Net Income Avi to Common (ttm)

    476.25M

  • Diluted EPS (ttm)

    10.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    908.72M

  • Total Debt/Equity (mrq)

    3.21%

  • Levered Free Cash Flow (ttm)

    405.5M

Research Analysis: 6523.TWO

View More

People Also Watch